- Home
- LSPD vs AMPH Comparison
LSPD vs AMPH Comparison
Compare LSPD & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSPD
- AMPH
- Stock Information
- Founded
- LSPD 2005
- AMPH 1996
- Country
- LSPD Canada
- AMPH United States
- Employees
- LSPD N/A
- AMPH N/A
- Industry
- LSPD
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- LSPD
- AMPH Health Care
- Exchange
- LSPD Nasdaq
- AMPH Nasdaq
- Market Cap
- LSPD 2.5B
- AMPH 2.5B
- IPO Year
- LSPD 2020
- AMPH 2014
- Fundamental
- Price
- LSPD $15.13
- AMPH $51.45
- Analyst Decision
- LSPD Buy
- AMPH Buy
- Analyst Count
- LSPD 14
- AMPH 4
- Target Price
- LSPD $18.46
- AMPH $63.00
- AVG Volume (30 Days)
- LSPD 476.3K
- AMPH 268.7K
- Earning Date
- LSPD 11-07-2024
- AMPH 11-06-2024
- Dividend Yield
- LSPD N/A
- AMPH N/A
- EPS Growth
- LSPD N/A
- AMPH 62.07
- EPS
- LSPD N/A
- AMPH 3.15
- Revenue
- LSPD $966,275,000.00
- AMPH $712,891,000.00
- Revenue This Year
- LSPD $24.83
- AMPH $18.04
- Revenue Next Year
- LSPD $17.62
- AMPH $4.41
- P/E Ratio
- LSPD N/A
- AMPH $16.26
- Revenue Growth
- LSPD 26.19
- AMPH 31.80
- 52 Week Low
- LSPD $11.01
- AMPH $36.56
- 52 Week High
- LSPD $21.71
- AMPH $65.92
- Technical
- Relative Strength Index (RSI)
- LSPD 46.02
- AMPH 59.40
- Support Level
- LSPD $14.77
- AMPH $49.38
- Resistance Level
- LSPD $15.92
- AMPH $51.84
- Average True Range (ATR)
- LSPD 0.32
- AMPH 1.25
- MACD
- LSPD -0.20
- AMPH 0.10
- Stochastic Oscillator
- LSPD 16.67
- AMPH 78.90
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, New Zealand, United Kingdom, Australia, Germany, and other countries. It derives a majority of its revenue from the United States.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.